Trinity Biotech | TRIB - Current Liabilities

Stock Price
0.78
Daily Change
-0.04 -4.76%
Monthly
2.15%
Yearly
-15.68%
Q1 Forecast
0.79

Trinity Biotech reported $34.49M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Abbott USD 14.58B 1.14B Sep/2025
Bayer EUR 28.96B 825M Sep/2025
Bio-Rad Laboratories USD 522.3M 26.6M Sep/2025
EDAP TMS EUR 34.12M 562K Jun/2025
J&J USD 50.87B 3.31B Sep/2025
Roche Holding CHF 28B 421M Dec/2025
Siemens EUR 47.26B 3.29B Sep/2025
Thermo Fisher Scientific USD 15.19B 301M Dec/2025
Tosoh JPY 314.44B 22.76B Sep/2025
Trinity Biotech USD 34.49M 2.97M Sep/2025
Veracyte USD 72.15M 4.28M Sep/2025